Colgate-Palmolive Company (CL) is drawing investor attention, outperforming fellow competitors despite recent market losses. A strong contender for a stable dividend stock, it offers a respectable 46% return over the last five years. Despite StockNews.com lowering their rating for CL, the company is largely backed by institutional shareholders, owning around 85%. Analysts have reflected varying opinions with some reducing the price target, amidst others championing its steady returns in uncertain market conditions. Observations from the company's Q3 2024 earnings call indicate robust organic sales growth. Analysts are intrigued by the stock's potential for significant appreciation. Influential financial authorities such as Wells Fargo and UBS have nuanced views on Colgate-Palmolive's current position and future growth. Investors are bullish about the company extending its 129-year dividend streak with a promising $0.50 quarterly payout. Amidst all the attention, institutional investors saw a short-term 5.0% loss over the last week, which contrasts with the long term profit dynamics. According to Wall Street projections, key metrics for Q3 2024 are insightful, and the intrinsic value of the company appears to supersede its current share price.
Colgate-Palmolive Company CL News Analytics from Wed, 01 May 2024 07:00:00 GMT to Fri, 10 Jan 2025 21:46:00 GMT -
Rating 7
- Innovation 6
- Information 5
- Rumor 3
